Abstract #2808

Prediction of multiple sclerosis clinical progression using whole brain adiabatic T1rho and Relaxation Along a Fictitious Field imaging

Ivan Jambor¹, Aida Steiner², Marko Pesola³, Timo Liimatainen⁴, Marcus Sucksdorff³, Eero Rissanen ², Laura Airas², Hannu Aronen³, and Harri Merisaari³

¹Icahn School of Medicine at Mount Sinai, New York, NY, United States, ²Turku University Hospital, Turku, Finland, ³University of Turku, Turku, Finland, ⁴University of Oulu, Oulu, Finland

In this single center prospective clinical trial, we have shown feasibility of whole brain of T1ρadiab and TRAFF2 at 3T. Both of these methods provided higher lesion-to-normal appearing white matter contrast compared with conventional used T1-weighted imaging, and demonstrated potential to predict multiple sclerosis disease severity scores (EDSS, MSSS) at the time of imaging and 1-year follow-up. These encouraging findings stimulate further application of T1ρadiab and TRAFF2 at 3T in patients with multiple sclerosis.

This abstract and the presentation materials are available to members only; a login is required.

Join Here